Mammography

Latest News



Radiologists and surgeons doubt the potential value of federal legislation aimed at improved breast cancer awareness among young women and more extensive disease management for patients who undergo breast surgery.

The largest study to date comparing film-screen and full-field digital mammography found the digital approach better for visualizing microcalcifications deemed crucial to diagnosing ductal carcinoma in situ.

With the goal of tailoring cancer interventions for the individual, researchers at the Lombardi Comprehensive Cancer Center at Georgetown University have published the results of a prospective study that validates the use of a simple blood test to help doctors more reliably assess treatment effectiveness for patients with metastatic breast cancer.

The largest population-based study to date comparing film-screen mammography and full-field digital mammography has found the digital approach is superior for visualizing microcalcifications deemed crucial to diagnosing ductal carcinoma in situ. No other significant difference in the diagnostic capabilities of the digital and analog approaches was identified.

ACR prepares to launch mammo database next monthFDA clears attenuation correction softwareCarestream readies value-priced laser imager MedRad unveils informatics product

FloSeal Matrix Hemostatic Sealant may stanch bleeding when other techniques fail, but it also spawns microcalcifications on digital or analog screening mammography that could lead to false positives for breast cancer, according to a case series collected by Loyola University radiologists.

Distrust of healthcare providers, cultural barriers, lack of information about the benefits of screening, or simply the need to cut corners might all contribute to the levels of compliance for breast cancer screening among minorities, including African American, Hispanic, and lesbian/bisexual women, recent studies show.